Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Equivalence Study of Mometasone Nasal Spray

NCT01850823 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT01850823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Equivalence Study of Mometasone Nasal Spray
Lead sponsor
Actavis Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2013
Enrollment
880 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis